Skip to main content
. 2021 Dec 9:kqab164. doi: 10.1093/occmed/kqab164

Table 1.

Comparison of different prevalence measures of SARS CoV-2 antibodies (unadjusted)

Population Positive SARS-CoV-2 PCR prior to studya Anti-SARS CoV-2 seroprevalence
(unadjusted)
Participants with neutralizing antibodies tittersb
Employees of the fire department
Total = 745
Total of the sample % [95% CI] 3% [1.7–4.1] 5% [3.3–6.3] 4% [2.4–5.1]
Total 20 34 26
Number of those with positive by PCR prior to study (%c) 14 (41%) 11 (42%)
Number of those who are seropositive (%c) 14 (70%) b
Number of those with neutralizing antibody titters (%c) 11 (55%) 26 (76%)

aSelf-reported SARS-CoV-2 infection (positive by RT-PCR) since February 2020.

bOnly in case of a positive Roche Cobas Elecsys® Anti-SARS-CoV-2 test, neutralizing antibody titter assay was performed.

cColumn percentages related to the total number with positive PCR or search or neutralization test.